Sign in

NCT03291652Recruiting

Morphology of Advanced Symptomatic Cerebral Plaques With High Embolic Potential

Source: ClinicalTrials.gov · Last updated 24 Feb 2026

Brief summary (registry, in English)

The study is to attain early recognition of the unstable plaques which have an imminent embolic risk in patients with intracranial atherosclerotic disease (IAD).

Status (registry)
Recruiting
Study type
Observational
Enrollment
140 (estimated)
First submitted
20 Sept 2017
Start date
1 Feb 2010
Primary completion date
23 Dec 2026
Lead sponsor
Chinese University of Hong Kong
Diseases
Stroke
NCT number
NCT03291652

What you commit to

  • Study type: Observational
  • Planned participants: 140
  • From 1 Feb 2010 to the primary completion date, 23 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Stroke etiology uncertain or unrelated to intracranial atherosclerosis, such as cardioembolism, Moyamoya disease, small vessel disease, etc.
  • A medical condition that would not allow the patient to adhere to the protocol or complete the study.

Lab values

  • Bleeding propensity: active peptic ulcer disease, major systemic hemorrhage within 30 days, thrombocytopenia (platelets \<100 x 109/L), coagulopathy (INR \>1.5).

Other

  • Subject who meets one or more of the following criteria cannot be recruited in the study:
  • A tandem stenosis \>50% at proximal internal carotid artery.

Who the study is looking for

  • Inclusion Criteria for the Symptomatic Group:
    • Patient is 30 to 85 years of age, inclusive.
    • Patients who have an acute infarct in diffusion-weighted MRI compatible with artery-to-artery thrombo-embolism, a relevant intracranial atherosclerotic stenosis ≥60%, and MES detected by TCD.
    • Patient who has no contra-indication for the proposed imaging tests.
    • Patient understands the purpose and requirements of the study, and has provided an informed consent.
  • Inclusion Criteria for the Asymptomatic Group:
    • Patient is 30 to 85 years of age, inclusive.
    • Patient who has a high-grade (\>60%) intracranial stenosis (signal void in MR angiography) but without infarct in the corresponding vascular territory in DWI or T2-weighted sequence.
    • Patient has no MES detected on TCD examination.
    • Patient who has no contra-indication for the proposed imaging tests.
    • Patient understands the purpose and requirements of the study, and has provided an informed consent.

Age in the registry: 30 years to 85 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Chinese University of Hong Kong
Coordinator of this site? Confirm its status
Hong KongHong Kong SAR ChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.